| Year |
Citation |
Score |
| 2016 |
Kwon DH, Eom GH, Ko JH, Shin S, Joung H, Choe N, Nam YS, Min HK, Kook T, Yoon S, Kang W, Kim YS, Kim HS, Choi H, Koh JT, ... ... Mendrysa SM, et al. MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification. Nature Communications. 7: 10492. PMID 26832969 DOI: 10.1038/Ncomms10492 |
0.342 |
|
| 2014 |
Mendrysa SM, Malek R. Abstract B16: Dissecting MDM2 function in medulloblastoma pathogenesis Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-B16 |
0.751 |
|
| 2012 |
Wang G, Fulkerson CM, Malek R, Ghassemifar S, Snyder PW, Mendrysa SM. Mutations in Lyar and p53 are synergistically lethal in female mice. Birth Defects Research. Part a, Clinical and Molecular Teratology. 94: 729-37. PMID 22815056 DOI: 10.1002/Bdra.23048 |
0.686 |
|
| 2012 |
Ghassemifar S, Mendrysa SM. MDM2 antagonism by nutlin-3 induces death in human medulloblastoma cells. Neuroscience Letters. 513: 106-10. PMID 22343310 DOI: 10.1016/J.Neulet.2012.02.022 |
0.576 |
|
| 2012 |
Malek R, Taylor N, Mendrysa SM. Abstract 5213: MDM2 at the crossroads of cell fate decisions in cerebellar development and medulloblastoma Cancer Research. 72: 5213-5213. DOI: 10.1158/1538-7445.Am2012-5213 |
0.752 |
|
| 2011 |
McGowan KA, Pang WW, Bhardwaj R, Perez MG, Pluvinage JV, Glader BE, Malek R, Mendrysa SM, Weissman IL, Park CY, Barsh GS. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood. 118: 3622-33. PMID 21788341 DOI: 10.1182/Blood-2010-11-318584 |
0.665 |
|
| 2011 |
Mendrysa SM, Ghassemifar S, Malek R. p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer. Genes & Cancer. 2: 431-42. PMID 21779511 DOI: 10.1177/1947601911409736 |
0.729 |
|
| 2011 |
Malek R, Matta J, Taylor N, Perry ME, Mendrysa SM. The p53 inhibitor MDM2 facilitates Sonic hedgehog-mediated tumorigenesis and influences cerebellar foliation Plos One. 6. PMID 21437245 DOI: 10.1371/Journal.Pone.0017884 |
0.745 |
|
| 2010 |
Mendrysa SM, Akagi K, Roayaei J, Lien WH, Copeland NG, Jenkins NA, Eisenman RN. An Integrated Genetic-Genomic Approach for the Identification of Novel Cancer Loci in Mice Sensitized to c-Myc-Induced Apoptosis. Genes & Cancer. 1: 465-479. PMID 20927200 DOI: 10.1177/1947601910374875 |
0.385 |
|
| 2006 |
Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, Teunisse A, Lam S, Ramos Y, Mohan A, Johnson D, Wilson M, Rodriguez-Galindo C, Quarto M, Francoz S, ... Mendrysa SM, et al. Inactivation of the p53 pathway in retinoblastoma. Nature. 444: 61-6. PMID 17080083 DOI: 10.1038/Nature05194 |
0.584 |
|
| 2006 |
Mendrysa SM, Perry ME. Tumor suppression by p53 without accelerated aging: Just enough of a good thing? Cell Cycle. 5: 714-717. PMID 16582632 DOI: 10.4161/Cc.5.7.2632 |
0.591 |
|
| 2006 |
Mendrysa SM, O'Leary KA, McElwee MK, Michalowski J, Eisenman RN, Powell DA, Perry ME. Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes & Development. 20: 16-21. PMID 16391230 DOI: 10.1101/Gad.1378506 |
0.579 |
|
| 2005 |
Cowley SM, Iritani BM, Mendrysa SM, Xu T, Cheng PF, Yada J, Liggitt HD, Eisenman RN. The mSin3A chromatin-modifying complex is essential for embryogenesis and T-cell development. Molecular and Cellular Biology. 25: 6990-7004. PMID 16055712 DOI: 10.1128/Mcb.25.16.6990-7004.2005 |
0.39 |
|
| 2004 |
O'Leary KA, Mendrysa SM, Vaccaro A, Perry ME. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues. Molecular and Cellular Biology. 24: 186-91. PMID 14673154 DOI: 10.1128/Mcb.24.1.186-191.2004 |
0.619 |
|
| 2003 |
Mendrysa SM, McElwee MK, Michalowski J, O'Leary KA, Young KM, Perry ME. mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation. Molecular and Cellular Biology. 23: 462-72. PMID 12509446 DOI: 10.1128/Mcb.23.2.462-473.2003 |
0.636 |
|
| 2001 |
Michalowski J, Seavey SE, Mendrysa SM, Perry ME. Defects in transcription coupled repair interfere with expression of p90MDM2 in response to ultraviolet light Oncogene. 20: 5856-5864. PMID 11593391 DOI: 10.1038/Sj.Onc.1204721 |
0.56 |
|
| 2001 |
Mendrysa SM, McElwee MK, Perry ME. Characterization of the 5′ and 3′ untranslated regions in murine mdm2 mRNAs Gene. 264: 139-146. PMID 11245988 DOI: 10.1016/S0378-1119(00)00589-8 |
0.477 |
|
| 2000 |
Mendrysa SM, Perry ME. The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress Molecular and Cellular Biology. 20: 2023-2030. PMID 10688649 DOI: 10.1128/Mcb.20.6.2023-2030.2000 |
0.575 |
|
| 2000 |
Perry ME, Mendrysa SM, Saucedo LJ, Tannous P, Holubar M. p76(MDM2) inhibits the ability of p90(MDM2) to destabilize p53 Journal of Biological Chemistry. 275: 5733-5738. PMID 10681559 DOI: 10.1074/Jbc.275.8.5733 |
0.574 |
|
| 1996 |
Bertin J, Mendrysa SM, LaCount DJ, Gaur S, Krebs JF, Armstrong RC, Tomaselli KJ, Friesen PD. Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease. Journal of Virology. 70: 6251-9. PMID 8709252 DOI: 10.1128/Jvi.70.9.6251-6259.1996 |
0.44 |
|
| Show low-probability matches. |